Old Web
English
Sign In
Acemap
>
authorDetail
>
Andric Zoran
Andric Zoran
Oncology
Internal medicine
Medicine
in patient
Pathology
5
Papers
3
Citations
0
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (5)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
Trial in progress: A phase 3, randomized, double-blind trial of trilaciclib versus placebo in patients receiving first- or second-line gemcitabine and carboplatin for locally advanced unresectable or metastatic triple-negative breast cancer (PRESERVE 2).
2021
Journal of Clinical Oncology
Shom Goel
Joyce OShaughnessy
Antoinette R. Tan
Boris Krastev
Hope S. Rugo
Philippe Aftimos
Denise A. Yardley
Andric Zoran
Curt Douglas Wolfgang
Jessica A. Sorrentino
Wenli Tao
Beelen Andrew
Rajesh K. Malik
Sarika Jain
Show All
Source
Cite
Save
Citations (0)
Bevacizumab biosimilar (MB02) and reference bevacizumab in patients with stage IIIB/IV non-squamous non-small cell lung cancer (NSCLC) (STELLA study): Multiple Imputation analysis.
2021
Journal of Clinical Oncology
Dmytro Trukhin
Elena Poddubskaya
Andric Zoran
Igor Bondarenko
Serhii Shevnia
Bojan Zaric
Ravishankar Bellala
Chaiyut Charoentum
Luis Figuero Pérez
Felicitas Bullo
Fernanda Rafaela Garcia
Show All
Source
Cite
Save
Citations (0)
HERIZON: A phase 1B/2 open-label study of imu-131 HER2/neu peptide vaccine PLUS standard of care chemotherapy with randomization in phase 2 in patients with HER2/neu overexpressing metastatic or advanced adenocarcinoma of the stomach or gastroesophageal junction.
2021
Journal of Clinical Oncology
Rita Laeufle
Marina Maglakelidze
Iurie Bulat
Dinara Ryspayeva
Andric Zoran
Tanuj Chawla
Ivan Nikolić
Rajnish Nagarkar
Giri Venkata
Vaibhav Choudhary
Davorin Radosavljevic
Rajesh Kumar Singh
Ursula Wiedermann
Anthony J. Good
Nick Ede
Leslie Chong
Show All
Source
Cite
Save
Citations (0)
Myelopreservation and reduced use of supportive care with trilaciclib in patients with small cell lung cancer.
2020
Journal of Clinical Oncology
Jared Weiss
Jerome H. Goldschmidt
Andric Zoran
Konstantin H. Dragnev
Yili L. Pritchett
Shannon R. Morris
Rajesh K. Malik
Davey B. Daniel
Show All
Source
Cite
Save
Citations (3)
Bevacizumab biosimilar and reference bevacizumab in subjects with stage IIIB/IV no squamous non-small cell lung cancer (NSCLC) (STELLA study): Results for the primary endpoint in a confirmatory, double-blind, randomized, controlled study.
2020
Journal of Clinical Oncology
Susana Millan
Dmytro Trukhin
Oleksii Kolesnik
Elena Poddubskaya
Andric Zoran
Igor Bondarenko
Serhii Shevnia
Felicitas Bullo
Cristina Sarnago
Show All
Source
Cite
Save
Citations (0)
1